Reference health
Antimicrobial Peptides and Their Analogs: Searching for New Potential Therapeutics
92/92 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 92 checked references that resolve
resolves10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9
Structural features and biological activities of the cathelicidin-derived antimicrobial peptides
resolves10.1038/nbt1267
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
resolves10.1002/pro.5560021208
Structure and orientation of the antibiotic peptide magainin in membranes by solid‐state nuclear magnetic resonance spectroscopy
resolves10.1128/AAC.44.3.602-607.2000
Antibacterial and Antimembrane Activities of Cecropin A in
<i>Escherichia coli</i>
resolves10.1016/j.bbamem.2006.03.030
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
resolves10.1007/s10529-005-0936-5
Human Antimicrobial Peptides: Defensins, Cathelicidins and Histatins
resolves10.1186/1472-6807-7-21
Conformational study of the protegrin-1 (PG-1) dimer interaction with lipid bilayers and its effect
resolves10.1016/j.bpj.2012.12.038
Membrane Interactions and Pore Formation by the Antimicrobial Peptide Protegrin
resolves10.1016/S0006-3495(97)78713-7
Bilayer Interactions of Indolicidin, a Small Antimicrobial Peptide Rich in Tryptophan, Proline, and Basic Amino Acids
resolves10.1074/jbc.274.1.29
Interaction of the Cyclic Antimicrobial Cationic Peptide Bactenecin with the Outer and Cytoplasmic Membrane
resolves10.1007/s10534-010-9324-2
Effect of loop structure of bovine lactoferricin on apoptosis in Jurkat cells
resolves10.1016/j.tibtech.2011.05.001
The expanding scope of antimicrobial peptide structures and their modes of action
resolves10.1021/cb1001558
Describing the Mechanism of Antimicrobial Peptide Action with the Interfacial Activity Model
resolves10.3390/ijms12095971
The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation
resolves10.1016/j.bbamem.2012.02.017
Comparative molecular dynamics simulations of the antimicrobial peptide CM15 in model lipid bilayers
resolves10.1016/j.clim.2009.12.004
Antimicrobial peptides: General overview and clinical implications in human health and disease
resolves10.1007/s12272-012-0302-9
Antimicrobial peptides: Their physicochemical properties and therapeutic application
resolves10.3390/polym4010539
Antimicrobial Peptides: Multifunctional Drugs for Different Applications
resolves10.1016/j.bbamem.2006.04.006
Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action
resolves10.1038/nrmicro1098
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
resolves10.1016/j.coph.2006.04.006
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
resolves10.1002/psc.338
Bulky aromatic amino acids increase the antibacterial activity of 15‐residue bovine lactoferricin derivatives
resolves10.2174/092986707779313435
The Medicinal Chemistry of Short Lactoferricin-Based Antibacterial Peptides
resolves10.1139/o01-213
Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides
resolves10.1016/j.femsle.2004.08.048
Factors contributing to the potency of antimicrobial cationic peptides from the N-terminal region of human lactoferrin
resolves10.1002/psc.629
Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin
resolves10.1124/jpet.109.162826
Metabolic Fate of Lactoferricin-Based Antimicrobial Peptides: Effect of Truncation and Incorporation of Amino Acid Analogs on the In Vitro Metabolic Stability
resolves10.1016/j.peptides.2011.07.017
Discovery and development of a synthetic peptide derived from lactoferrin for clinical use
resolves10.1371/journal.pone.0012684
Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs
resolves10.1128/AAC.00828-06
Length Effects in Antimicrobial Peptides of the (RW)<sub><i>n</i></sub>Series
resolves10.1021/jm049582b
Bulky Nonproteinogenic Amino Acids Permit the Design of Very Small and Effective Cationic Antibacterial Peptides
resolves10.1021/jm200450h
A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption
resolves10.1128/AAC.38.10.2280
Identification of antimicrobial peptides by using combinatorial libraries made up of unnatural amino acids
resolves10.1111/j.1365-2672.1995.tb01671.x
The antimicrobial activity of hexapeptides derived from synthetic combinatorial libraries
resolves10.1042/bj3130141
Rapid identification of compounds with enhanced antimicrobial activity by using conformationally defined combinatorial libraries
resolves10.1002/psc.351
Structure–function relationships in the tryptophan‐rich, antimicrobial peptide indolicidin
resolves10.1016/j.chembiol.2006.08.014
Sequence Requirements and an Optimization Strategy for Short Antimicrobial Peptides
resolves10.1016/j.bbamem.2007.02.005
Omiganan interaction with bacterial membranes and cell wall models. Assigning a biological role to saturation
resolves10.1016/j.ijantimicag.2009.05.003
Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models
resolves10.1016/j.bmc.2006.06.027
The introduction of fluorine atoms or trifluoromethyl groups in short cationic peptides enhances their antimicrobial activity
resolves10.1021/jm3002058
Targeting the S1 and S3 Subsite of Trypsin with Unnatural Cationic Amino Acids Generates Antimicrobial Peptides with Potential for Oral Administration
resolves10.1021/jm1006337
Unnatural Amino Acid Side Chains as S1, S1′, and S2′ Probes Yield Cationic Antimicrobial Peptides with Stability toward Chymotryptic Degradation
resolves10.1128/AAC.00300-10
Easy Strategy To Protect Antimicrobial Peptides from Fast Degradation in Serum
resolves10.2174/1381612033392279
Antimicrobial Compounds of Low Molecular Mass are Constitutively Present in Insects: Characterisation of &#946;-Alanyl-Tyrosine
resolves10.1021/jm900622d
Discovery of Trp-His and His-Arg Analogues as New Structural Classes of Short Antimicrobial Peptides
resolves10.1039/B815368J
Antimicrobial activity, biocompatibility and hydrogelation ability of dipeptide-based amphiphiles
resolves10.1111/j.1365-2672.2012.05385.x
Identification of antimicrobial compound, diketopiperazines, from a Bacillus sp. N strain associated with a rhabditid entomopathogenic nematode against major plant pathogenic fungi
resolves10.1002/psc.2594
Cyclo(<scp>d</scp>-Tyr-<scp>d</scp>-Phe): a new antibacterial, anticancer, and antioxidant cyclic dipeptide from<i>Bacillus</i>sp. N strain associated with a rhabditid entomopathogenic nematode
resolves10.1007/s00018-011-0717-3
Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches
resolves10.1159/000104751
Amphiphilic Dendrimeric Peptides as Model Non-Sequential Pharmacophores with Antimicrobial Properties
resolves10.1021/bi035142v
Bestowing Antifungal and Antibacterial Activities by Lipophilic Acid Conjugation to <scp>d</scp>,<scp>l</scp>-Amino Acid-Containing Antimicrobial Peptides: A Plausible Mode of Action
resolves10.1128/AAC.00344-06
In Vitro Activities of the Lipopeptides Palmitoyl (Pal)-Lys-Lys-NH
<sub>2</sub>
and Pal-Lys-Lys Alone and in Combination with Antimicrobial Agents against Multiresistant Gram-Positive Cocci
resolves10.1111/j.1747-0285.2010.00973.x
Antimicrobial Activity of Short, Synthetic Cationic Lipopeptides
resolves10.1111/cbdd.12182
Systematic Study of Non‐Natural Short Cationic Lipopeptides as Novel Broad‐Spectrum Antimicrobial Agents
resolves10.1021/jm901052r
Antimicrobial Activity of Small β-Peptidomimetics Based on the Pharmacophore Model of Short Cationic Antimicrobial Peptides
resolves10.1016/j.chembiol.2008.03.006
Structure-Activity Relationships of Antibacterial Acyl-Lysine Oligomers
resolves10.1128/AAC.00010-09
Antibacterial Properties and Mode of Action of a Short Acyl-Lysyl Oligomer
resolves10.1002/cmdc.201100358
A Comparison of Linear and Cyclic Peptoid Oligomers as Potent Antimicrobial Agents
resolves10.1016/j.bmc.2006.02.034
Potent antibacterial lysine–peptoid hybrids identified from a positional scanning combinatorial library
resolves10.2174/138161212799277617
Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections
The 1 reference without a DOI — listed, not checked
no DOI — not checkedbibr33-PMC.S13215
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.4137/pmc.s13215"><img src="https://citestamp.com/citestamped/10.4137/pmc.s13215/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.4137/pmc.s13215)